"Unsealing" is about to talk about "immunity"
Release time:
2020-07-15
On March 24, the Hubei Province Novel Coronavirus Infection Pneumonia Epidemic Prevention and Control Headquarters issued a notice: From 0:00 on March 25, areas outside Wuhan City will be lifted from the control of the exit channel; from 0:00 on April 8, Wuhan City will lift the control measures of the exit channel from Han and Hubei. On March 25, Wuhan's first "subway to spring" resumed operation. Hubei "restart", Wuhan "unsealed", officially entered the countdown.
The "epidemic" of the war has brought irreparable pain to the Chinese people and caused huge losses to the Chinese economy. At present, "unsealing" is imminent, we should also calm down and seriously reflect on how to face all kinds of uncertain and sudden tests in the future.
As the director of the Department of Infectious Diseases of Huashan Hospital Affiliated to Fudan University and the leader of the Shanghai Medical Treatment Expert Group, Dr. Zhang Wenhong, "New Internet Celebrity", has repeatedly stated, "Before the special antiviral drugs come out, the most effective drug It is human immunity. Now what the medical staff do is not only to help all the patients who come in for treatment and isolate the virus, but also to help the patients survive for two weeks. After two weeks, the patient's own antibodies will rise. The doctor's job is to help the patient get through this stage."
Indeed, in the face of the "undifferentiated blow" of the new coronavirus, some people are fine, some are sick; some of the sick people, some have recovered smoothly, some have died unfortunately; some have recovered quickly, some have recovered slowly. The difference of individual immunity formed by age, physical fitness, hygiene habits and other factors has played a decisive role in this "war epidemic" without specific drugs.
Similar to the epidemic in life, the unprecedented long economic shutdown has also brought another sense of epidemic to many businesses. The extended holiday is not over yet, and a succession of companies have posted announcements of bankruptcy and closure on the Internet, and there are even more people struggling on the line of life and death. Some experts have pointed out that the epidemic has broken the established work arrangements of almost all enterprises, and the resulting changes in the internal and external environment may be a watershed for many enterprises.
Usually in the operation of the enterprise, almost every enterprise manager will say that it is necessary to strengthen internal control, reduce costs and increase efficiency. However, when the development of the industry and the market is in good times, many things that are not in place will be covered up. When the market growth is not obvious or decline, what does the enterprise adjust? Rely on efficiency, rely on layout. If you do the same thing faster and earlier than others, you will become active; if you layout different things earlier and faster, you will get the first opportunity.
In a crisis, survival is the key, and to be able to survive, one of the ways out is model innovation. Business models, business models, operation and management models, and work models all need innovation. Because the epidemic prevention and control needs to delay the resumption of work, many enterprises to start the "new construction" mode, so that employees at home, online, on the job to start work or study, to help employees with the new work mode to enter the working state. The remote online work model not only solves the problem of delayed resumption of work but also provides a new possibility for a large number of employees eager to return to work and enter a normal life.
The epidemic has completely changed the external environment in which companies operate, and most of the business models and business models that companies were familiar with before the epidemic may not be appropriate in the face of the epidemic. Even many companies that are themselves online models will encounter various unprecedented challenges such as affordability, technical capabilities, rapid response capabilities, changes in the industrial chain and value network, which require companies to abandon the original model and create new models. If the company is still relying on the traditional model for development and does not make a fundamental change, its development will be restricted or even eliminated; if it can quickly transform itself, turn the crisis into self-change, and seek opportunities for new development, it will Usher in a new development.
With the unremitting efforts of scientists, a specific medicine will be born one day, allowing us to firmly "lock the new coronavirus in a cage"; but for companies, when and in what way the future test will come It is always unknown to what extent, and there will never be a specific medicine to treat the company's diseases. If you want to successfully survive the various "epidemics" that will inevitably exist in the future ", we can only constantly" exercise "and improve the" immunity "of enterprises". (one word)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page